Insulet (PODD) EPS (Basic) (QoQ) (2010 - 2026)
Insulet (PODD) EPS (Basic) (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn |
| 10 | Insulet | 10.34 Bn | 9.81 Bn | 562.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.32% |
| Mar 31, 2026 | -9.96% |
| Dec 31, 2025 | 16.13% |
| Sep 30, 2025 | 289.46% |
| Jun 30, 2025 | -36.73% |
| Mar 31, 2025 | -64.85% |
| Dec 31, 2024 | 30.02% |
| Sep 30, 2024 | -58.94% |
| Jun 30, 2024 | 265.66% |
| Mar 31, 2024 | -50.34% |
| Dec 31, 2023 | 99.43% |
| Sep 30, 2023 | 89.89% |
| Jun 30, 2023 | 14.45% |
| Mar 31, 2023 | 39.58% |
| Dec 31, 2022 | 427.13% |
| Sep 30, 2022 | 85.16% |
| Jun 30, 2022 | -225.71% |
| Mar 31, 2022 | -6.93% |
| Dec 31, 2021 | 135.75% |
| Sep 30, 2021 | 148.81% |